抑制剂溶液
Metabolism
GPCR/GProtein
Neuroscience
Apoptosis
Chromatin/Epigenetic
TyrosineKinase/Adaptors
Microbiology/Virology
Angiogenesis
CellCycle/Checkpoint
Membranetransporter/Ionchannel
Immunology/Inflammation
DNADamage/DNARepair
Autophagy
CytoskeletalSignaling
StemCells
PI3K/Akt/mTORsignaling
Proteases/Proteasome
MAPK
JAK/STATsignaling
Endocrinology/Hormones
Others
更多…
| 产品编号 | 图片 | 产品描述 | 分子式 | 加入购物车 | |
|---|---|---|---|---|---|
|
Fevipiprant，98% | C19H17F3N2O4S | |||
|
|
|||||
|
MK-6892，99% | C19H22N4O5 | |||
|
|
|||||
|
MGL-3196，99% | C17H12Cl2N6O4 | |||
|
|
|||||
|
(+/-)-Equol，99% | C15H14O3 | |||
|
|
|||||
|
DY131，98% | C18H21N3O2 | |||
|
|
|||||
|
Atosiban，99% | C45H71N11O14S2 | |||
|
|
|||||
|
（S）-Equol，99% | C15H14O3 | |||
|
|
|||||
|
Tyr-Gly-Gly-Phe-Leu，99% | C28H37N5O7 | |||
|
|
|||||
|
Trh，98% | C16H22N6O4 | |||
|
|
|||||
|
Ciclesonide，99% | C32H44O7 | |||
|
|
|||||
|
Hydrocortisone Butyrate，98% | C25H36O6 | |||
|
|
|||||
|
H-Tyr-Gly-Gly-Phe-Met-OH，99% | C27H35N5O7S | |||
|
|
|||||
|
ARM390 HCl，98% | C23H29ClN2O | |||
|
|
|||||
|
ODM-201，98% | C19H19ClN6O2 | |||
|
|
|||||
|
A-779，98% | C39H60N12O11 | |||
|
|
|||||
|
AZD9496，99% | C25H25F3N2O2 | |||
|
|
|||||
|
BTB06584，98% | C19H12ClNO6S | |||
|
|
|||||
|
JTC-801，98% | C26H25N3O2·HCl | |||
|
|
|||||
|
Beclomethasone，98% | C22H29ClO5 | |||
|
|
|||||
|
Oxytocin，98% | C43H66N12O12S2 | |||
|
|
|||||
|
3,3',5-Triiodothyroacetic acid，98% | C14H9I3O4 | |||
|
|
|||||
|
N-Desmethyl Clozapine，98% | C17H17ClN4 | |||
|
|
|||||
|
LY404039，98% | C7H9NO6S | |||
|
|
|||||
|
(Z)-4-Hydroxytamoxifen，99% | C26H29NO2 | |||
|
|
|||||
|
OC000459，98% | C21H17FN2O2 | |||
|
|
|||||
|
Galeterone，≥98% | C26H32N2O | |||
|
|
|||||
|
Mirtazapine，99% | C17H19N3 | |||
|
|
|||||
